The Los Angeles Post
California & Local U.S. World Business Lifestyle
Today: January 19, 2025
Today: January 19, 2025
Maggie Fick

Maggie Fick

Staff Writer

Latest From Maggie Fick

Uncategorized

Exclusive-Catalent nears settlement with Elliott for board seats -sources

Catalent Inc is close to reaching a settlement with Elliott Investment Management that would lead to a shake-up of the U.S. contract drug manufacturer’s board of directors after its share price lost half of its value in the last year. The company is poised to agree to add four new directors proposed by Elliott to its board, which currently has 12 members, people familiar with the situation said on Monday. The sources declined to be identified because the information is confidential and cautioned a deal could still collapse at the last minute. Spokespeople

Exclusive-Catalent nears settlement with Elliott for board seats -sources
Business|Economy|Finance|Health

Weight-loss drugs fuel boom for firms that fill syringes

Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the

Weight-loss drugs fuel boom for firms that fill syringes
Business|Economy|Health|US

Novo Nordisk to 'significantly' boost U.S. Wegovy doses next year

Novo Nordisk said on Thursday it will supply "significantly" more doses of Wegovy in the U.S. next year, even as it cautioned

Novo Nordisk to 'significantly' boost U.S. Wegovy doses next year
Business|Economy|Health

Novo Nordisk, Lilly see insatiable demand for weight-loss drugs

Novo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by their

Novo Nordisk, Lilly see insatiable demand for weight-loss drugs
Health|Lifestyle|Technology

How well-off Brits still buy Ozempic online for weight loss

John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator.

How well-off Brits still buy Ozempic online for weight loss
Business|Health|Science|Technology|US

Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms

Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big

Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms
Business|Health|US

Exclusive-US FDA finds new manufacturing lapses at Eli Lilly plant

U.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators,

Exclusive-US FDA finds new manufacturing lapses at Eli Lilly plant
Business|Economy|Europe|Health

As Lilly competition heats up, Novo CEO details strategy for new Wegovy launches

Novo Nordisk will target launches of its mega popular obesity shot Wegovy in markets where it already has strong sales of its

As Lilly competition heats up, Novo CEO details strategy for new Wegovy launches
Health|Science

Novo kidney trial finds Ozempic cuts cardiac risks in diabetics

Novo Nordisk's widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, a large late-stage study

Novo kidney trial finds Ozempic cuts cardiac risks in diabetics
Business|Europe|Health

Novo Nordisk hopes to launch experimental obesity drug this decade

Novo Nordisk's head of development on Friday told Reuters he was very comfortable the drugmaker would be able to launch the

Novo Nordisk hopes to launch experimental obesity drug this decade
Business|Finance|Stock Markets

AstraZeneca leaps after smashing first-quarter forecasts

AstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by demand for its blockbuster drugs and steady sales from

AstraZeneca leaps after smashing first-quarter forecasts
Business|Economy|Finance|Health|Science

GSK raises profit outlook on strong vaccine, HIV drug sales

GSK raised its full-year profit forecast on Wednesday on strong demand for its common respiratory vaccine and specialty HIV medicines, though it expects sales

GSK raises profit outlook on strong vaccine, HIV drug sales
Business|Europe|Health

Novo Nordisk trims price for blockbuster obesity drug as competition heats up

Novo Nordisk raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of its Wegovy weight-loss treatment, while

Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Health|MidEast|World

Main maternity hospital in Rafah stops admitting patients

The main maternity hospital in the Gaza Strip's crowded southern city of Rafah has stopped admitting patients, the United Nations Population Fund (UNFPA) said on

Main maternity hospital in Rafah stops admitting patients
Business|Finance|Stock Markets

AstraZeneca aims for $80 billion in total revenue by 2030

AstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by the expected launch of 20 new medicines and through

AstraZeneca aims for $80 billion in total revenue by 2030
Health|Science

Wegovy users have less kidney-related health problems, analysis of Novo study finds

Novo Nordisk's Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese people in a large study, according to a new analysis the

Wegovy users have less kidney-related health problems, analysis of Novo study finds
Business|Finance|Health|US

GSK shares slide after US health agency narrows scope of RSV shots

GSK shares fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed its age recommendation for use of respiratory syncytial virus

GSK shares slide after US health agency narrows scope of RSV shots
World

Gaza's child amputees face further risks without expert care

Eleven-year-old Noor's left leg was almost entirely torn off when her home in Jabalia, Gaza was hit by an explosion in

Gaza's child amputees face further risks without expert care
MidEast|News|World

How many Palestinians have died in Gaza war and how will the counting continue?

Israeli forces unleashed an aerial and ground blitz against Hamas in Gaza after a cross-border rampage by the enclave's ruling

How many Palestinians have died in Gaza war and how will the counting continue?
MidEast|News|World

Displaced Gazans cram into Rafah despite fears of attack

Tens of thousands of displaced Palestinians have crammed into the Rafah area on Gaza's border with Egypt to escape Israeli bombardments,

Displaced Gazans cram into Rafah despite fears of attack
News|World

Despite Gaza death toll soaring, U.S. unlikely to rethink weapons supplies to Israel

Facing a soaring death toll from Israel's renewed offensive in southern Gaza, the Biden administration is trying to

Despite Gaza death toll soaring, U.S. unlikely to rethink weapons supplies to Israel
Business|Health|Science

Eli Lilly: still seeking UK approval on pen for weight-loss drug

Eli Lilly on Thursday said it has not yet gained approval in Britain for the injection pen it plans to use for its Mounjaro drug against obesity and

Eli Lilly: still seeking UK approval on pen for weight-loss drug
Business|Europe|Health

Weight-loss drugs in spotlight as pharma services firms rush to snap up business

Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmaceutical services industry this week, as it fuels a boom for

Weight-loss drugs in spotlight as pharma services firms rush to snap up business
Business|Health

Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing

Obesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular

Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing
Business|Health|Science|Technology

GSK buys COVID, influenza vaccines from retrenching CureVac

British drugmaker GSK on Wednesday bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA credentials and extending the

GSK buys COVID, influenza vaccines from retrenching CureVac

Follow